|Bid||352.67 x 900|
|Ask||352.96 x 800|
|Day's Range||349.63 - 355.16|
|52 Week Range||282.21 - 387.42|
|Beta (5Y Monthly)||0.42|
|PE Ratio (TTM)||26.48|
|Earnings Date||Feb 05, 2024 - Feb 09, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||400.00|
Subscribe to Yahoo Finance Plus to view Fair Value for VRTX
GSK vs. VRTX: Which Stock Is the Better Value Option?
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.
These stocks are already big winners in 2023 and should keep their momentum going in a new bull market.